- Home
- RLAY vs AVO Comparison
RLAY vs AVO Comparison
Compare RLAY & AVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- AVO
- Stock Information
- Founded
- RLAY 2015
- AVO 1983
- Country
- RLAY United States
- AVO United States
- Employees
- RLAY N/A
- AVO N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- AVO Farming/Seeds/Milling
- Sector
- RLAY Health Care
- AVO Consumer Staples
- Exchange
- RLAY Nasdaq
- AVO Nasdaq
- Market Cap
- RLAY 723.1M
- AVO 860.1M
- IPO Year
- RLAY 2020
- AVO 2020
- Fundamental
- Price
- RLAY $4.94
- AVO $12.07
- Analyst Decision
- RLAY Strong Buy
- AVO Strong Buy
- Analyst Count
- RLAY 10
- AVO 2
- Target Price
- RLAY $20.11
- AVO $15.50
- AVG Volume (30 Days)
- RLAY 2.9M
- AVO 538.9K
- Earning Date
- RLAY 02-20-2025
- AVO 03-10-2025
- Dividend Yield
- RLAY N/A
- AVO N/A
- EPS Growth
- RLAY N/A
- AVO N/A
- EPS
- RLAY N/A
- AVO 0.52
- Revenue
- RLAY $10,006,000.00
- AVO $1,234,700,000.00
- Revenue This Year
- RLAY N/A
- AVO N/A
- Revenue Next Year
- RLAY N/A
- AVO N/A
- P/E Ratio
- RLAY N/A
- AVO $23.96
- Revenue Growth
- RLAY N/A
- AVO 29.44
- 52 Week Low
- RLAY $3.50
- AVO $9.54
- 52 Week High
- RLAY $11.16
- AVO $15.25
- Technical
- Relative Strength Index (RSI)
- RLAY 53.29
- AVO 38.00
- Support Level
- RLAY $3.50
- AVO $12.26
- Resistance Level
- RLAY $5.99
- AVO $12.65
- Average True Range (ATR)
- RLAY 0.54
- AVO 0.38
- MACD
- RLAY 0.06
- AVO -0.12
- Stochastic Oscillator
- RLAY 49.40
- AVO 13.28
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About AVO Mission Produce Inc.
Mission Produce Inc is engaged in the business of producing and distributing avocados, serving retail, wholesale, and food service customers. Also, the company provides additional services like ripening, bagging, custom packing, and logistical management. The company's operating segments include Marketing and Distribution and International Farming and Blueberries. It generates maximum revenue from the Marketing and Distribution segment. The Marketing and Distribution segment sources fruit mainly from growers and then distributes fruit through a distribution network.